Home Authors Posts by Nancy Valente, MD

Nancy Valente, MD

Nancy Valente, MD
Nancy Valente, M.D., brings more than 20 years of industry and academic experience to her role as Head of Hematology Development at Genentech, where she leads the clinical development strategy for the company’s portfolio of hematology medicines. As a board-certified hematologist and medical oncologist, she is focused on improving outcomes for people with diseases of the blood, including cancers and hemophilia. She has published research on hematology, solid tumors, and immunotherapy in leading scientific journals, and is an active member of the American Society of Clinical Oncology, the American Association for Cancer Research, and the American Society of Hematology.

Three Essential Lessons About Blood Cancer Today

Now is the time to turn the lessons of recent years into insights that help people with blood cancer so they can survive and thrive as long as possible.